tiprankstipranks
Advertisement
Advertisement

CAMP Stock Latest News

CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
Company AnnouncementsCAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
4d ago
8K
CAMP
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
PremiumRatings
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
10d ago
CAMP
Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c)
PremiumThe Fly
Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c)
11d ago
CAMP
Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw
1M ago
CAMP
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
PremiumThe Fly
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
2M ago
CAMP
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board
PremiumCompany AnnouncementsCAMP4 Therapeutics Adds Veteran CFO MacLean to Board
2M ago
8K
CAMP
CAMP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CAMP Earnings this Week: How Will it Perform?
2M ago
CAMP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
CAMP
SPRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
CAMP
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress
PremiumCompany Announcements
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress
2M ago
8K
CAMP
Camp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
PremiumThe Fly
Camp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
3M ago
CAMP
CAMP4 Therapeutics updates corporate investor presentation materials
PremiumCompany Announcements
CAMP4 Therapeutics updates corporate investor presentation materials
4M ago
8K
CAMP
CAMP4 Therapeutics Restructures Leases and Expands Facilities
PremiumCompany AnnouncementsCAMP4 Therapeutics Restructures Leases and Expands Facilities
5M ago
8K
CAMP
CAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy Rating
Premium
Ratings
CAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy Rating
5M ago
CAMP
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
Premium
Company Announcements
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
5M ago
8K
CAMP
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
PremiumRatings
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
5M ago
CAMP
CAMP4, GSK form RNA therapeutics collaboration agreement
PremiumCompany Announcements
CAMP4, GSK form RNA therapeutics collaboration agreement
5M ago
8K
CAMP
Camp4 Therapeutics prices 5M shares at $6.00 in underwritten public offering
PremiumThe Fly
Camp4 Therapeutics prices 5M shares at $6.00 in underwritten public offering
5M ago
CAMP
Camp4 Therapeutics 5M share Secondary priced at $6.00
PremiumThe Fly
Camp4 Therapeutics 5M share Secondary priced at $6.00
5M ago
CAMP
Camp4 Therapeutics, GSK enter strategic collaboration
PremiumThe FlyCamp4 Therapeutics, GSK enter strategic collaboration
5M ago
GSK
CAMP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
CAMP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
CAMP
IBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >